MECLIZINE HYDROCHLORIDE TABLETS, 25 mg, Packaged in a) 100 ct Bottles (NDC: 60429-205-01) and b) ...

FDA Recall #D-0510-2016 — Class III — November 25, 2015

Recall #D-0510-2016 Date: November 25, 2015 Classification: Class III Status: Terminated

Product Description

MECLIZINE HYDROCHLORIDE TABLETS, 25 mg, Packaged in a) 100 ct Bottles (NDC: 60429-205-01) and b) 1000 ct Bottles (NDC: 60429-205-10), Rx Only. Manufactured by: Par Pharmaceuticals Companies Inc., Spring Valley, NY 10977. Packaged by: GSMS Incorporated, Carmarillo, CA 93012.

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for impurities.

Recalling Firm

Golden State Medical Supply Inc. — Camarillo, CA

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

a) 737 Bottles; b) 3863 Bottles

Distribution

U.S. Nationwide

Code Information

a) Lot #: GS005224, Expiry: Jul-16, Lot:#: GS007553, Expiry: Nov-17; Lot #: GS007858, Expiry: Nov-17. b) Lot #: GS002674, Expiry: Jan-16; Lot #: GS003402, Expiry:May-16; Lot #: GS003582, Expiry: Jun-16; Lot #: GS004899, Expiry: Jun-16; Lot #: GS005908, Expiry: Jun-17; Lot #: GS006088, Expiry: Jun-17; Lot #: GS006254, Expiry: Sep-17; Lot #: GS007345, Expiry: Nov-17; Lot #: GS007664, Expiry: Nov-17; Lot #: GS007803, Expiry: Nov-17; Lot #: GS008091, Expiry: Nov-17.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated